The Filings Report

Bristol-Myers Squibb insider trading

BMYfinancial statementsForm 4 filings on EDGAR308 transactions since Nov 1, 2024

From August 4, 2026 to November 1, 2026, 0 insiders at Bristol-Myers Squibb bought $0 of stock in the open market, and 2 sold $437K. Officers and directors accounted for $0 of purchases and $437K of sales. The last reported transaction was an option exercise by Gallman Cari on October 2, 2026.

The answer card and chart use the same period. Change the range above the chart to update both. Form 4 filings through October 5, 2026; awards, option exercises, tax withholding and gifts are excluded from these totals.

Stock price and insider activity

Daily price candles with insider purchases and sales directly beneath them on the same timeline. Bars show individual days; totals sum all days in the selected period.

BMY daily priceSplit-adjusted prices in US dollars

Bought $0Sold $437KAug 4, 2026 – Nov 1, 2026

Oct 30, 2026O $63.00 · H $64.05 · L $62.29 · C $62.48Bought $0 (0)Sold $0 (0)
$55$59$62$66$692026-08-04: open $64.89, high $66.31, low $63.87, close $65.892026-08-05: open $64.81, high $65.41, low $63.26, close $63.632026-08-06: open $64.90, high $64.94, low $63.20, close $64.152026-08-07: open $64.24, high $64.73, low $63.79, close $64.722026-08-10: open $64.33, high $65.25, low $64.12, close $64.842026-08-11: open $64.56, high $65.02, low $63.54, close $63.612026-08-12: open $63.49, high $64.00, low $63.00, close $63.702026-08-13: open $64.05, high $65.02, low $63.91, close $64.652026-08-14: open $64.13, high $64.33, low $63.35, close $63.832026-08-17: open $63.60, high $64.74, low $63.36, close $64.632026-08-18: open $65.30, high $66.38, low $65.00, close $66.052026-08-19: open $66.80, high $68.64, low $66.61, close $67.612026-08-20: open $67.23, high $67.54, low $65.45, close $65.472026-08-21: open $65.79, high $67.55, low $65.13, close $67.012026-08-24: open $67.41, high $67.41, low $66.45, close $67.282026-08-25: open $66.42, high $68.05, low $66.42, close $67.922026-08-26: open $67.74, high $68.00, low $67.32, close $67.572026-08-27: open $66.59, high $67.47, low $66.20, close $66.952026-08-28: open $66.77, high $66.84, low $66.19, close $66.582026-08-31: open $66.25, high $67.20, low $65.91, close $66.812026-09-01: open $67.58, high $68.04, low $66.65, close $66.922026-09-02: open $66.82, high $67.73, low $66.75, close $67.662026-09-03: open $68.08, high $68.23, low $66.62, close $68.092026-09-04: open $67.24, high $67.72, low $66.58, close $66.822026-09-08: open $65.66, high $65.89, low $64.39, close $64.692026-09-09: open $64.57, high $65.05, low $64.26, close $64.412026-09-10: open $64.92, high $64.92, low $63.73, close $63.752026-09-11: open $64.15, high $64.20, low $63.27, close $63.642026-09-14: open $64.59, high $65.27, low $63.91, close $64.102026-09-15: open $63.94, high $64.13, low $63.15, close $63.732026-09-16: open $64.07, high $64.39, low $63.22, close $63.602026-09-17: open $64.08, high $64.35, low $62.52, close $62.842026-09-18: open $62.71, high $63.07, low $62.19, close $63.062026-09-21: open $63.09, high $63.40, low $62.62, close $62.622026-09-22: open $62.73, high $63.08, low $62.03, close $62.252026-09-23: open $62.31, high $62.65, low $61.08, close $61.152026-09-24: open $61.40, high $61.59, low $60.60, close $61.502026-09-25: open $61.75, high $62.91, low $61.40, close $62.862026-09-28: open $62.77, high $63.93, low $62.30, close $63.882026-09-29: open $63.58, high $63.89, low $61.95, close $62.862026-09-30: open $63.28, high $64.13, low $62.40, close $62.402026-10-01: open $62.20, high $62.61, low $61.25, close $61.462026-10-02: open $60.66, high $61.24, low $60.24, close $61.152026-10-05: open $59.89, high $60.15, low $58.33, close $58.812026-10-06: open $58.94, high $59.60, low $58.64, close $59.592026-10-07: open $59.45, high $60.10, low $59.01, close $59.702026-10-08: open $59.10, high $59.94, low $58.73, close $59.582026-10-09: open $58.88, high $59.79, low $58.74, close $59.122026-10-12: open $60.11, high $60.68, low $56.72, close $57.582026-10-13: open $57.78, high $58.02, low $56.15, close $56.672026-10-14: open $56.81, high $59.39, low $56.60, close $59.282026-10-15: open $60.67, high $62.25, low $60.39, close $60.572026-10-16: open $61.10, high $61.43, low $59.54, close $59.752026-10-19: open $59.40, high $59.87, low $58.44, close $58.832026-10-20: open $59.93, high $61.82, low $59.83, close $61.682026-10-21: open $61.50, high $61.81, low $60.69, close $61.122026-10-22: open $61.46, high $63.59, low $61.04, close $63.002026-10-23: open $62.66, high $62.84, low $61.31, close $61.482026-10-26: open $61.39, high $62.06, low $61.11, close $61.612026-10-27: open $61.21, high $61.64, low $60.92, close $61.552026-10-28: open $60.50, high $61.34, low $60.33, close $60.572026-10-29: open $61.00, high $61.56, low $60.00, close $61.392026-10-30: open $63.00, high $64.05, low $62.29, close $62.48Insider purchases / sales · USD$500K$0−$500K2026-08-25: 0 purchases ($0), 1 sales ($34K)2026-09-09: 0 purchases ($0), 1 sales ($403K)Aug 4Aug 26Sep 17Oct 9Oct 30

purchases above zero; sales below. Both use the transaction date and the same dollar scale. Hover, tap, or use arrow keys to inspect a date. Awards, exercises, tax withholding and gifts are excluded.

Dates with prices or insider activity are spaced evenly; empty weekends and holidays are omitted. Prices through Oct 30, 2026. Insider data through Nov 1, 2026. Prices are adjusted for splits; transaction values are reported dollars.

Every transaction

308 transactions from November 1, 2024 to November 1, 2026, newest first. Open-market purchases and sales are coloured; awards, exercises, tax withholding and gifts are grey and not counted.

TradedInsiderRoleTransactionSharesPriceValueHeld afterFiled
Oct 2, 2026Gallman CariEVP, General Counseloption exercise4,559$0.00—18,208Oct 5, 2026
Oct 2, 2026Gallman CariEVP, General Counseltax withholding2,332$61.15$143K15,876Oct 5, 2026
Sep 9, 2026Massacesi CristianEVP,Chief Med Offr,Head of Devopen-market sale6,249$64.57$403K18,748Sep 10, 2026
Sep 1, 2026Short Bartie WendyEVP, Corporate Affairsoption exercise1,236$66.92$83K13,317Sep 3, 2026
Sep 1, 2026Short Bartie WendyEVP, Corporate Affairstax withholding633$66.92$42K12,684Sep 3, 2026
Aug 25, 2026Holzer Phil MSVP and Controlleropen-market sale500$67.50$34K16,862Aug 26, 2026
Aug 1, 2026Massacesi CristianEVP,Chief Med Offr,Head of Devoption exercise51,172$0.00—51,172Aug 4, 2026
Aug 1, 2026Massacesi CristianEVP,Chief Med Offr,Head of Devtax withholding26,175$65.31$2M24,997Aug 4, 2026
Aug 1, 2026Gallman CariEVP, General Counseloption exercise1,061$0.00—14,192Aug 4, 2026
Aug 1, 2026Gallman CariEVP, General Counseltax withholding543$65.31$35K13,649Aug 4, 2026
Jun 15, 2026Haller Julia ADirectoroption exercise20,460$53.76$1M34,079Jun 16, 2026
Jun 3, 2026Short Bartie WendyEVP, Corporate Affairsoption exercise8,040$0.00—15,957Jun 5, 2026
Jun 3, 2026Short Bartie WendyEVP, Corporate Affairstax withholding3,876$54.72$212K12,081Jun 5, 2026
May 1, 2026Lenkowsky AdamEVP, Chief Commercial Officeroption exercise1,373$0.00—20,508May 5, 2026
May 1, 2026Lenkowsky AdamEVP, Chief Commercial Officerother203$0.00—20,305May 5, 2026
May 1, 2026Lenkowsky AdamEVP, Chief Commercial Officertax withholding599$58.22$35K19,706May 5, 2026
Apr 1, 2026Shanahan KarinEVP, Chief Supply Chain & Opsoption exercise3,307$0.00—27,580Apr 2, 2026
Apr 1, 2026Shanahan KarinEVP, Chief Supply Chain & Opstax withholding1,692$61.73$104K25,888Apr 2, 2026
Apr 1, 2026Elkins David VEVP, Chief Financial Officeropen-market sale25,519$61.60$2M163,729Apr 2, 2026
Apr 1, 2026Elkins David VEVP, Chief Financial Officeropen-market sale4,481$62.05$278K159,248Apr 2, 2026
Mar 10, 2026Short Bartie WendyEVP, Corporate Affairsoption exercise749$0.00—6,780Mar 12, 2026
Mar 10, 2026Short Bartie WendyEVP, Corporate Affairsother81$0.00—6,699Mar 12, 2026
Mar 10, 2026Short Bartie WendyEVP, Corporate Affairstax withholding242$60.13$15K6,457Mar 12, 2026
Mar 10, 2026Short Bartie WendyEVP, Corporate Affairsoption exercise4,495$0.00—10,952Mar 12, 2026
Mar 10, 2026Short Bartie WendyEVP, Corporate Affairsoption exercise639$0.00—6,308Mar 12, 2026
Mar 10, 2026Short Bartie WendyEVP, Corporate Affairstax withholding828$60.13$50K7,917Mar 12, 2026
Mar 10, 2026Short Bartie WendyEVP, Corporate Affairstax withholding205$60.13$12K6,031Mar 12, 2026
Mar 10, 2026Short Bartie WendyEVP, Corporate Affairsother2,207$0.00—8,745Mar 12, 2026
Mar 10, 2026Short Bartie WendyEVP, Corporate Affairsother72$0.00—6,236Mar 12, 2026
Mar 10, 2026Shanahan KarinEVP, Chief Supply Chain & Opsother356$0.00—20,863Mar 12, 2026
Mar 10, 2026Shanahan KarinEVP, Chief Supply Chain & Opsoption exercise3,293$0.00—21,219Mar 12, 2026
Mar 10, 2026Shanahan KarinEVP, Chief Supply Chain & Opstax withholding1,112$60.13$67K17,926Mar 12, 2026
Mar 10, 2026Shanahan KarinEVP, Chief Supply Chain & Opsother275$0.00—19,038Mar 12, 2026
Mar 10, 2026Shanahan KarinEVP, Chief Supply Chain & Opsoption exercise2,448$0.00—19,313Mar 12, 2026
Mar 10, 2026Shanahan KarinEVP, Chief Supply Chain & Opstax withholding1,503$60.13$90K19,360Mar 12, 2026
Mar 10, 2026Shanahan KarinEVP, Chief Supply Chain & Opsoption exercise19,760$0.00—39,120Mar 12, 2026
Mar 10, 2026Shanahan KarinEVP, Chief Supply Chain & Opsother9,702$0.00—29,418Mar 12, 2026
Mar 10, 2026Shanahan KarinEVP, Chief Supply Chain & Opstax withholding5,145$60.13$309K24,273Mar 12, 2026
Mar 10, 2026Plenge Robert MEVP, Chief Research Officertax withholding3,172$60.13$191K21,528Mar 12, 2026
Mar 10, 2026Plenge Robert MEVP, Chief Research Officerother6,900$0.00—24,700Mar 12, 2026
Mar 10, 2026Plenge Robert MEVP, Chief Research Officertax withholding927$60.13$56K17,548Mar 12, 2026
Mar 10, 2026Plenge Robert MEVP, Chief Research Officerother253$0.00—18,475Mar 12, 2026
Mar 10, 2026Plenge Robert MEVP, Chief Research Officeroption exercise2,342$0.00—18,728Mar 12, 2026
Mar 10, 2026Plenge Robert MEVP, Chief Research Officertax withholding436$60.13$26K16,386Mar 12, 2026
Mar 10, 2026Plenge Robert MEVP, Chief Research Officerother124$0.00—16,822Mar 12, 2026
Mar 10, 2026Plenge Robert MEVP, Chief Research Officeroption exercise1,107$0.00—16,946Mar 12, 2026
Mar 10, 2026Plenge Robert MEVP, Chief Research Officeroption exercise14,052$0.00—31,600Mar 12, 2026
Mar 10, 2026Meyers Gregory ScottEVP, Chief Digital & Tech Off.option exercise3,293$0.00—26,172Mar 12, 2026
Mar 10, 2026Meyers Gregory ScottEVP, Chief Digital & Tech Off.tax withholding1,069$60.13$64K22,879Mar 12, 2026
Mar 10, 2026Meyers Gregory ScottEVP, Chief Digital & Tech Off.other319$0.00—23,948Mar 12, 2026

Who the insiders are

Everyone who reported a transaction since November 1, 2024, by open-market value over twelve months. Shares held are after the insider’s latest directly held transaction.

InsiderRoleLast transactionKindShares heldBought, 12 monthsSold, 12 monthsSales under a plan
Elkins David VEVP, Chief Financial OfficerApr 1, 2026open-market sale163,729—$2M (2)0 of 2
Massacesi CristianEVP,Chief Med Offr,Head of DevSep 9, 2026open-market sale18,748—$403K (1)0 of 1
Holzer Phil MSVP and ControllerAug 25, 2026open-market sale16,862—$34K (1)0 of 1
Boerner Christopher S.Chief Executive Officer, DirectorMar 10, 2026other10,057———
Gallman CariEVP, General CounselOct 2, 2026option exercise18,208———
Lenkowsky AdamEVP, Chief Commercial OfficerMay 1, 2026option exercise20,508———
Shanahan KarinEVP, Chief Supply Chain & OpsApr 1, 2026option exercise27,580———
Meyers Gregory ScottEVP, Chief Digital & Tech Off.Mar 10, 2026option exercise26,172———
Plenge Robert MEVP, Chief Research OfficerMar 10, 2026tax withholding21,528———
Hoch LynellePresident, Cell Therapy Org.Mar 10, 2026option exercise5,549———
Poole Ahn AmandaEVP, Chief People OfficerMar 10, 2026other5,916———
Short Bartie WendyEVP, Corporate AffairsSep 1, 2026option exercise13,317———
Hirawat SamitEVP,Chief Med.Offr.,Drug Dev.Apr 25, 2025open-market buy83,513———
Leung SandraEVP, General CounselMar 10, 2025tax withholding352,206———
Hickey BenjaminPresident, RayzeBio Org.Feb 27, 2026option exercise18,344———
Haller Julia ADirectorJun 15, 2026option exercise34,079———

Questions

Are Bristol-Myers Squibb insiders buying or selling?

Over the twelve months to November 1, 2026, 3 insiders at Bristol-Myers Squibb sold $2M of stock in the open market, all by officers and directors, and no insider bought. Net, insiders sold $2M. Only open-market purchases and sales are counted.

Who sold the most Bristol-Myers Squibb stock in the last year?

Elkins David V (EVP, Chief Financial Officer) sold $2M in 2 open-market sales over the twelve months to November 1, 2026.

Do Bristol-Myers Squibb executives sell under 10b5-1 plans?

0 of the 4 open-market sales in the last twelve months (0%) were reported as made under a Rule 10b5-1 trading plan, set up in advance. A sale under a plan is still counted as a sale.

What counts as insider buying here?

Only open-market purchases (Form 4 code P) and sales (code S) by officers, directors and 10% owners. Stock awards, option exercises, shares withheld for tax and gifts are listed in the table but never counted as buying or selling.

More on Bristol-Myers Squibb

From Form 4, 4/A and 5 filings with the SEC. A record of insider transactions, not a recommendation.